Clinical Trials
22 trialsNCT03666559 2024-02-29
AGIR
Assistance Publique - Hôpitaux de Paris
Phase 2 Unknown
NCT04197492 2024-01-05
Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas
Huashan Hospital
Phase 2 Unknown
NCT05611645 2022-11-10
Low-dose Bevacizumab With HSRT vs BVZ Alone for GBM at First Recurrence
Huashan Hospital
Phase 2 Unknown
NCT00075387 2022-05-03
Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors
OHSU Knight Cancer Institute
Phase 2 Unknown
NCT03932981 2021-09-10
TEMOTRAD01
Assistance Publique - Hôpitaux de Paris
Phase 2 Unknown
NCT04822805 2021-03-30
A Study of Anlotinib in the Treatment of Recurrent High-grade Glioma
First People's Hospital of Hangzhou
Phase 2 Unknown
NCT04668508 2020-12-16
Anlotinib to Malignant Brainstem Glioma
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT04588987 2020-10-19
Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma
Sun Yat-sen University
Phase 2 Unknown
NCT01567202 2020-09-09
Study of DC Vaccination Against Glioblastoma
Huashan Hospital
Phase 2 Unknown
NCT00276783 2020-03-05
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
Northwestern University
Phase 2 Unknown
NCT03741244 2019-07-23
TMZ Plus Apatinib in Newly Diagnosed High-grade Glioma：RCT
The Second Hospital of Hebei Medical University
Phase 2 Unknown
NCT03390062 2018-01-04
A Study of Apatinib in Recurrent or Recurrent High-grade Glioma
West China Hospital
Phase 2 Unknown
NCT00575796 2017-09-20
Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)
The Hospital for Sick Children
Phase 2 Unknown
NCT02772094 2016-05-13
Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)
China Medical University Hospital
Phase 2 Unknown
NCT01403311 2014-03-26
ALA
Legacy Health System
Phase 2 Unknown
NCT01670890 2012-08-22
Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas
Peking Union Medical College Hospital
Phase 2 Unknown
NCT01144988 2011-08-02
AVIRMA01-09
Medical University Innsbruck
Phase 2 Unknown
NCT01252459 2010-12-16
GLIAA
University Hospital Freiburg
Phase 2 Unknown
NCT00660283 2010-01-20
KARE003
Kentuckiana Cancer Institute
Phase 2 Unknown
NCT00660621 2010-01-20
KARE004
Kentuckiana Cancer Institute
Phase 2 Unknown
NCT00114309 2009-04-03
131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
TransMolecular
Phase 2 Unknown
NCT00283543 2007-10-31
Radiation With Concomitant and Then Sequential Temozolomide in Malignant Glioma
Kentuckiana Cancer Institute
Phase 2 Unknown